Cognex CLO sells 64,873 shares after option exercises
COGNEX CORP Chief Legal Officer & Secretary Mark Fennell reported a series of option exercises and related share sales in Common Stock.
Rhea-AI Filing Summary
COGNEX CORP Chief Legal Officer & Secretary Mark Fennell reported a series of option exercises and related share sales in Common Stock. On May 11, 2026, he exercised options to acquire a total of 60,010 shares at exercise prices ranging from $33.04 to $56.44 per share. On the same date, he executed open-market sales totaling 64,873 shares at prices including $66.73 and $67.08 per share. Following these transactions, Fennell directly holds 4,863 shares of Cognex Common Stock. Footnotes describe prior option grants that vest in annual installments over several years.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
26 txns
Insider
Fennell Mark
Role
Chief Legal Officer &Secretary
Sold
64,873 shs ($4.35M)
Approx. gross sale proceeds
$4.35M
Approx. exercise cost
$2.72M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 6,634 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 15,080 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 4,000 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 18,296 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 6,400 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 9,600 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,400 | $51.49 | $330K |
| Sale | Common Stock | 6,400 | $67.08 | $429K |
| Exercise | Common Stock | 18,296 | $47.21 | $864K |
| Sale | Common Stock | 18,296 | $67.08 | $1.23M |
| Exercise | Common Stock | 15,080 | $39.44 | $595K |
| Sale | Common Stock | 15,080 | $67.08 | $1.01M |
| Exercise | Common Stock | 6,634 | $33.04 | $219K |
| Sale | Common Stock | 6,634 | $67.08 | $445K |
| Exercise | Common Stock | 9,600 | $56.44 | $542K |
| Sale | Common Stock | 9,600 | $67.08 | $644K |
| Exercise | Common Stock | 4,000 | $42.84 | $171K |
| Sale | Common Stock | 4,000 | $67.08 | $268K |
| Sale | Common Stock | 4,863 | $66.73 | $325K |
| Grant/Award | Non-Qualified Stock Option (right to buy) | 7,231 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 11,211 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 9,685 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 3,169 | $0.00 | $0.00 |
| Grant/Award | Non-Qualified Stock Option (right to buy) | 22,412 | $0.00 | $0.00 |
| Grant/Award | Non-Qualified Stock Option (right to buy) | 30,464 | $0.00 | $0.00 |
| Grant/Award | Non-Qualified Stock Option (right to buy) | 8,921 | $0.00 | $0.00 |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 152,788 contracts (Direct);
Restricted Stock Unit — 24,065 contracts (Direct);
Common Stock — 0 shares (Direct)
Footnotes (6)
- F1. The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
- F2. The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2024).
- F3. The options vest approximately 50% on the third anniversary of the grant date (October 31, 2018) and 50% on the fourth anniversary of the grant date.
- F4. The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 21, 2023).
- F5. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).
- F6. The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
Key Figures
Shares sold: 64,873 shares
Shares from option exercises: 60,010 shares
Sale price example: $66.73/share
+4 more
7 metrics
Shares sold
64,873 shares
Open-market sales of Cognex Common Stock on May 11, 2026
Shares from option exercises
60,010 shares
Common Stock acquired via option exercises on May 11, 2026
Sale price example
$66.73/share
One open-market sale price for Common Stock on May 11, 2026
Sale price example
$67.08/share
Additional open-market sale price for Common Stock on May 11, 2026
Post-transaction holdings
4,863 shares
Direct Cognex Common Stock held by Fennell after transactions
Option exercise price
$33.04/share
Exercise price for one non-qualified stock option grant
Option exercise price
$56.44/share
Exercise price for another non-qualified stock option grant
Key Terms
Non-Qualified Stock Option (right to buy), Restricted Stock Unit, open-market sale, Exercise or conversion of derivative security, +2 more
6 terms
Non-Qualified Stock Option (right to buy) financial
"security_title: "Non-Qualified Stock Option (right to buy)""
Restricted Stock Unit financial
"security_title: "Restricted Stock Unit""
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
vest in five approximately equal annual installments financial
"footnote: "The options vest in five approximately equal annual installments""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Cognex (CGNX) report for Mark Fennell?
Cognex reported that Chief Legal Officer & Secretary Mark Fennell exercised options for 60,010 Common Stock shares and sold 64,873 shares in open-market transactions on May 11, 2026. These trades reflect option exercises followed by share dispositions.
What options did Mark Fennell exercise in the latest Cognex (CGNX) Form 4?
The Form 4 shows Fennell exercised options covering 60,010 Common Stock shares, with exercise prices including $33.04, $39.44, $42.84, $47.21, $51.49, and $56.44. These non-qualified stock options converted into common shares on May 11, 2026.
Are vesting schedules disclosed for Mark Fennell’s Cognex (CGNX) stock options?
Yes. Footnotes explain that several option grants vest in five approximately equal annual installments starting on specific grant anniversaries, while one grant vests 50% on the third anniversary and 50% on the fourth, detailing how his awards become exercisable over time.
Does the Cognex (CGNX) Form 4 show any new RSU or option awards to Mark Fennell?
The data includes derivative entries for Restricted Stock Units and non-qualified stock options previously awarded, such as 11,211 RSUs and a 7,231-share option granted on February 17, 2026. These records outline existing compensation grants alongside the more recent exercises.
AI-generated analysis. How Rhea-AI works. Not financial advice.
